Title : Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies.

Pub. Date : 2004 Apr 15

PMID : 15073843






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 With the recent approval of bortezomib for patients with advanced multiple myeloma, NF-kappaB modulation is likely to be a therapeutic endeavor of increasing interest in coming years. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens